These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 526915)

  • 1. 1-year followup of cardiac status after adriamycin therapy.
    Friedman MJ; Ewy GA; Jones SE; Cruze D; Moon TE
    Cancer Treat Rep; 1979; 63(11-12):1809-16. PubMed ID: 526915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.
    Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ
    Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics and acute signs of cardiac toxicity during doxorubicin therapy].
    Lenzhofer R; Schneeweiss B; Rameis H; Eichler H; Graninger W; Dittrich C; Dudczak R; Ganzinger U; Gasic S; Moser K
    Wien Klin Wochenschr; 1983 Jan; 95(2):52-5. PubMed ID: 6858169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Echocardiography with angiotensin administration in the diagnosis of adriamycin-induced cardiomyopathy].
    Göldel N; Autenrieth G; Werdan K; Knesewitsch P; Wilmanns W
    Z Kardiol; 1989 May; 78(5):320-7. PubMed ID: 2735093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiomyopathy after osteosarcoma treatment: a contribution to the cardiotoxicity of adriamycin].
    Geidel S; Garn M; Grävinghoff L; Hausdorf G; Morf G; Bielack S; Knop J; Winkler K
    Klin Padiatr; 1991; 203(4):257-61. PubMed ID: 1942931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
    de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA
    Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monitoring of cardiac function during doxorubicin therapy in metastasized breast cancer. Measuring systolic time interval].
    Lenzhofer R; Dudczak R; Dittrich C; Gumhold G; Moser K; Spitzy KH
    Dtsch Med Wochenschr; 1983 May; 108(20):771-5. PubMed ID: 6840008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
    Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
    Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endomyocardial biopsy as a method of surveilling adriamycin cardiac toxicity. 28 biopsies in 26 patients].
    Bouhour JB; Petitier H; Delajartre AY; Fumoleau P; Rozo L; Nicolas G
    Arch Mal Coeur Vaiss; 1983 Nov; 76(11):1277-83. PubMed ID: 6419695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in left ventricular function during chemotherapy with doxorubicin].
    Elbl L; Chaloupka V; Vásová I; Kiss I; Jancík J; Vorlícek J; Navrátil M
    Vnitr Lek; 1999 Jul; 45(7):395-402. PubMed ID: 11045157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systolic time intervals and echocardiography in monitoring adriamycin-treated tumor patients].
    Schott G
    Z Gesamte Inn Med; 1991 Jun; 46(8):280-2. PubMed ID: 1897287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of adriamycin myocardiopathy using echocardiography].
    Harpf H; Lehnert M; Tschech G
    Acta Med Austriaca Suppl; 1979; 6():341-3. PubMed ID: 299226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval).
    Greco FA; Brereton HD; Rodbard D
    Cancer Treat Rep; 1976 Sep; 60(9):1239-45. PubMed ID: 797446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.
    Hequet O; Le QH; Moullet I; Pauli E; Salles G; Espinouse D; Dumontet C; Thieblemont C; Arnaud P; Antal D; Bouafia F; Coiffier B
    J Clin Oncol; 2004 May; 22(10):1864-71. PubMed ID: 15143078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Echocardiographic detection of adriamycin cardiotoxicity. Study of the relationship between the shortening fraction-constraint and the systolic shortening fraction-diameter of the left ventricle].
    Boujon B; Lechat P; Mantz J; Fraysse JB; Leblond V; Drobinski G; Lascault G; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1989 Feb; 82(2):167-75. PubMed ID: 2500077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiomyopathy due to adriamycin: the possibility of its prevention. Monitoring by noninvasive technics].
    Bianchi L; Bertocchi C; Felci U; Ferrario G; Giani P; Mariani L; Medolago G; Sarti E
    Minerva Med; 1989 Mar; 80(3):215-26. PubMed ID: 2717043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug-induced myocardial disease--adriamycin cardiotoxicity].
    Wakasugi S
    Nihon Rinsho; 2000 Jan; 58(1):204-11. PubMed ID: 10885315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive polygraphic cardiac changes in daunorubicin-induced cardiomyopathy in rabbits.
    Gersl V; Hrdina R
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1994; 37(2):49-55. PubMed ID: 7784798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ECG changes in adriamycin therapy].
    Pötzi P; Huber J; Kühböck J; Weber H
    Acta Med Austriaca Suppl; 1979; 6():339-41. PubMed ID: 299225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of left ventricular function in diabetics by studying systolic time intervals].
    Babalis D; Cokkinos D; Voridis E
    Arch Mal Coeur Vaiss; 1982 Nov; 75(11):1287-90. PubMed ID: 6818919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.